Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Alvaro

Showing results (11-20 of 240) with videos related to

Pageof 24
Sort By:
Molecular Aspects of Medicine|January 31, 2008
New insights on the molecular and cell biology of human cholangiopathiesDomenico Alvaro, Maria Grazia Mancino
Recenti Progressi in Medicina|November 30, 2007
[Pathophysiology of cholangiocytes: recent advances]Maria Grazia Mancino, Domenico Alvaro
Journal of Hepatology|June 15, 2024
Implications of mycophenolate mofetil in a reproductive age patient cohort: Maternal fetal medicine point of viewFabrizio Zullo, Vincenzo Cardinale, Domenico Alvaro
Current Opinion in Gastroenterology|February 6, 2024
Biliary stem cells in health and cholangiopathies and cholangiocarcinomaVincenzo Cardinale, Savino Paradiso, Domenico Alvaro
Clinical and Translational Gastroenterology|March 2, 2026
Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern?Vincenzo Cardinale, Lorenzo Ridola, Domenico Alvaro
Recenti Progressi in Medicina|January 23, 2019
[Inflammatory and neoplastic cholangiopathies.]Domenico Alvaro, Maria Consiglia Bragazzi, Lorenzo Ridola
Gastroenterology and Hepatology From Bed to Bench|July 14, 2017
New insights in IBS-like disorders: Pandora's box has been opened; a reviewRaffaele Borghini, Giuseppe Donato, Domenico Alvaro, et al.
Recenti Progressi in Medicina|February 24, 2021
[Evidence-based management of primary liver cancers: cholangiocarcinoma.]Domenico Alvaro, Maria Consiglia Bragazzi, Rosanna Venere, et al.
Recenti Progressi in Medicina|February 24, 2021
[FXR modulators and cholestatic diseases.]Domenico Alvaro, Maria Consiglia Bragazzi, Rosanna Venere, et al.
World Journal of Gastrointestinal Oncology|May 31, 2012
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneityVincenzo Cardinale, Guido Carpino, Lola Reid, et al.
Pageof 24

Showing results (11-20 of 240) with videos related to

Sort By:
Pageof 24
Molecular Aspects of Medicine|January 31, 2008
New insights on the molecular and cell biology of human cholangiopathiesDomenico Alvaro, Maria Grazia Mancino
Recenti Progressi in Medicina|November 30, 2007
[Pathophysiology of cholangiocytes: recent advances]Maria Grazia Mancino, Domenico Alvaro
Journal of Hepatology|June 15, 2024
Implications of mycophenolate mofetil in a reproductive age patient cohort: Maternal fetal medicine point of viewFabrizio Zullo, Vincenzo Cardinale, Domenico Alvaro
Current Opinion in Gastroenterology|February 6, 2024
Biliary stem cells in health and cholangiopathies and cholangiocarcinomaVincenzo Cardinale, Savino Paradiso, Domenico Alvaro
Clinical and Translational Gastroenterology|March 2, 2026
Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern?Vincenzo Cardinale, Lorenzo Ridola, Domenico Alvaro
Recenti Progressi in Medicina|January 23, 2019
[Inflammatory and neoplastic cholangiopathies.]Domenico Alvaro, Maria Consiglia Bragazzi, Lorenzo Ridola
Gastroenterology and Hepatology From Bed to Bench|July 14, 2017
New insights in IBS-like disorders: Pandora's box has been opened; a reviewRaffaele Borghini, Giuseppe Donato, Domenico Alvaro, et al.
Recenti Progressi in Medicina|February 24, 2021
[Evidence-based management of primary liver cancers: cholangiocarcinoma.]Domenico Alvaro, Maria Consiglia Bragazzi, Rosanna Venere, et al.
Recenti Progressi in Medicina|February 24, 2021
[FXR modulators and cholestatic diseases.]Domenico Alvaro, Maria Consiglia Bragazzi, Rosanna Venere, et al.
World Journal of Gastrointestinal Oncology|May 31, 2012
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneityVincenzo Cardinale, Guido Carpino, Lola Reid, et al.
Pageof 24